MISSISSAUGA, ON, Aug. 18, 2020 /CNW/ - Sanofi Canada announced today that Health Canada approved a new indication for DUPIXENT ® (dupilumab injection), as an add-on maintenance treatment with ...
Dupixent single-dose prefilled pens feature a hidden needle and single-press auto-injection. The Food and Drug Administration (FDA) has expanded the approval of the Dupixent ® (dupilumab) single-dose ...
Dupixent (dupilumab) is a subcutaneous injection prescribed to treat asthma. You’ll usually use it with other asthma medications. Dupixent is not a rescue medication for asthma attacks, however.
TORONTO, Oct. 22, 2025 /CNW/ - Health Canada has approved Dupixent® (dupilumab injection) as an add-on maintenance treatment in adult patients with chronic obstructive pulmonary disease (COPD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results